Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.68 is 24% below its 5-year average of 2.20, around the middle of its 5-year range (0.00–2.64).
As of the fiscal period ended Tuesday, June 30, 2026. 28.03% below its 12-month average of 2.33.
Reported quarterly current ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 1.68.
CURRENT RATIO
1.68
CURRENT RATIO AVG TTM
2.33
CURRENT RATIO AVG 3Y
2.24
CURRENT RATIO AVG 5Y
2.20
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-28.03%
CURRENT VS 3Y AVG
-25.17%
CURRENT VS 5Y AVG
-23.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-55.21%
vs the sector median at left
Market Cap
$357.37M
Current Ratio
3.76
TTM Avg
4.71
3Y Avg
6.65
5Y Avg
8.92
Market Cap
$356.40M
Current Ratio
5.85
TTM Avg
6.36
3Y Avg
5.52
5Y Avg
8.17
Market Cap
$353.90M
Current Ratio
8.26
TTM Avg
5.36
3Y Avg
5.81
5Y Avg
4.44
Market Cap
$354.94M
Current Ratio
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Embecta Corp. (EMBC) | $358.93M | 1.68 | 2.33 | 2.24 | 2.20 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.37M | 3.76 | 4.71 | 6.65 | 8.92 |
| Viemed Healthcare, Inc. (VMD)vs › | $356.92M | 1.13 | 1.30 | 1.47 | 1.77 |
| Turn Therapeutics Inc. (TTRX)vs › | $353.52M | 1.19 | 1.21 | 1.62 | 1.62 |
| Ocugen, Inc. (OCGN)vs › | $356.07M | 0.80 | 1.96 | 2.47 | 5.28 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.40M | 5.85 | 6.36 | 5.52 | 8.17 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.90M | 8.26 | 5.36 | 5.81 | 4.44 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $354.94M | 24.16 | 12.00 | 8.65 | 7.93 |
| Opus Genetics, Inc. (IRD)vs › | $365.67M | 12.19 | 4.83 | 10.20 | 8.85 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | 29.52 | 9.54 | 9.83 | 10.59 |
Current Ratio
1.68
Quick Ratio
1.68
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.68 |
| 2026-03-31 | 2.46 |
| 2025-12-31 | 2.64 |
| 2025-09-30 | 2.41 |
| 2025-06-30 | 2.47 |
| 2025-03-31 | 2.48 |
| 2024-12-31 | 2.24 |
| 2024-09-30 | 2.03 |
| 2024-06-30 | 2.11 |
| 2024-03-31 | 2.29 |
| 2023-12-31 | 2.20 |
| 2023-09-30 | 2.12 |
| 2023-06-30 | 2.04 |
| 2023-03-31 | 2.11 |
| 2022-12-31 | 2.06 |
| 2022-09-30 | 2.21 |
| 2022-06-30 | 2.54 |
| 2022-03-31 | 2.53 |
| 2021-12-31 | 1.62 |
| 2021-09-30 | 1.78 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
